Zespół badawczy Pawła Włodarskiego
Wybrane publikacje
| Publikacja | Impact Factor |
|---|---|
| Sajjad EA, Zieliński G, Maksymowicz M, Hutnik L, Bednarczuk T, Włodarski P. mTOR is frequently active in GH-secreting pituitary adenomas without Influencing their morphopathological features. Endocr Pathol 2013; 24: 11‒19. |
1,3 |
| Bil J, Włodarski P, Winiarska M, Kurzaj Z, Issat T, Józkowicz A, Wegiel B, Dulak J, Golab J. Photodynamic therapy-driven induction of suicide cytosine deaminase gene. Cancer Lett 2010; 290: 216‒222. |
4,8 |
| Ługowska A, Płoski R, Włodarski P, Tylki-Szymańska A. Molecular bases of metachromatic leukodystrophy in Polish patients. J Hum Genet 2010; 55: 394‒396. |
2,4 |
| Baryłko B, Mao YS, Włodarski P, Jung G, Binns DD, Sun HQ, Yin HL, Albanesi JP. Palmitoylation controls the catalytic activity and subcellular distribution of phosphatidylinositol 4-kinase IIα. J Biol Chem 2009; 284: 9994‒10003. |
5,3 |
| Jóźwiak J, Jóźwiak S, Włodarski P. Possible mechanisms of disease development in tuberous sclerosis. Lancet Oncol 2008; 9: 73‒79. |
13,2 |
| Jung G, Wang J, Włodarski P, Baryłko B, Binns DD, Shu H, Yin HL, Albanesi JP. Molecular determinants of activation and membrane targeting of phosphatidylinositol 4-kinase IIβ. Biochem J 2008; 409: 501‒509. |
4,3 |
| Włodarski P, Zhang Q, Liu X, Kasprzycka M, Marzec M, Wasik MA. PU.1 activates transcription of SHP-1 gene in hematopoietic cells. J Biol Chem 2007; 282: 6316‒6323. |
5,5 |
| Jóźwiak J, Grajkowska W, Włodarski P. Pathogenesis of medulloblastoma and current treatment outlook. Med Res Rev 2007; 27: 869‒90. |
7,2 |
| Włodarski P, Kasprzycka M, Liu X, Marzec M, Robertson ES, Słupianek A, Wasik MA. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of AKT mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Cancer Res 2005; 65: 7800‒7808. |
7,6 |
| Włodarski P, Wasik M, Ratajczak MZ, Sevignani C, Hoser G, Kawiak J, Gewirtz AM, Calabretta B, Skorski T. Role of p53 in hematopoietic recovery after cytotoxic treatment. Blood 1998; 91: 2998‒3006. |
8,3 |
| Stokłosa T, Głodkowska-Mrówka E, Hoser G, Kielak M, Seferyńska I, Włodarski P. Diverse Mechanisms of mTOR Activation in Chronic and Blastic Phase of Chronic Myelogenous Leukemia. Exp Hematol 2013; 41: 462‒469. | – |